Evidence map›Paper›PMID 42290406›Full record

ArticleChemistry & biodiversity2026

Thymol Chemotype Thymus vulgaris L. Hydrolate: Volatile Chemical Fraction Composition and Antimicrobial Activity Against Bacterial and Fungal Pathogens.

Stefania Garzoli, Joel Horacio Elizondo-Luevano, Anis Ben Hsouna, Rania Ben Saad, Miroslava Kačániová

Abstract read
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefania GarzoliDepartment of Chemistry and Technologies of Drug, Sapienza University, Rome, Italy.ORCID https://orcid.org/0000-0001-8535-0533
Joel Horacio Elizondo-LuevanoLaboratory of Natural Sciences, Biomolecular Innovation Group, Faculty of Agronomy, Universidad Autónoma de Nuevo León, Cd. Gral. Escobedo, Nuevo León, Mexico.ORCID https://orcid.org/0000-0003-2954-5939
Anis Ben HsounaLaboratory of Biotechnology and Plant Improvement, Centre of Biotechnology of Sfax, Sfax, Tunisia.
Rania Ben SaadLaboratory of Biotechnology and Plant Improvement, Centre of Biotechnology of Sfax, Sfax, Tunisia.
Miroslava KačániováInstitute of Horticulture, Faculty of Horticulture and Landscape Engineering, Slovak University of Agriculture, Nitra, Slovakia.ORCID https://orcid.org/0000-0002-4460-0222

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of antimicrobial resistance necessitates the development of alternative antimicrobial agents derived from natural sources. This study evaluated the volatile chemical profile and antimicrobial activity of a thymol-containing hydrolate obtained from Thymus vulgaris L. against a panel of 14 clinically and economically relevant microorganisms. Headspace-gas chromatography-mass spectrometry analysis revealed thymol (79.9%) and linalool (17.4%) as the predominant constituents of the hydrolate. Antimicrobial activity was assessed using disc diffusion and broth microdilution assays to determine inhibition zones and minimum inhibitory concentrations. The hydrolate exhibited pronounced activity against Gram-positive bacteria, with the largest inhibition zones observed for Staphylococcus aureus and the lowest MIC values for the same strain (MIC

Indexed as

Anti-Bacterial AgentsAntifungal AgentsThymolThymus PlantVolatile Organic CompoundsBotrytisCandida albicansGas Chromatography-Mass SpectrometryGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAntifungal AgentsThymolVolatile Organic Compoundsantimicrobial activitybacteriafilamentous fungiHS‐GC‐MSnatural preservativeThymus vulgaris hydrolateyeasts

Identifiers

PMID42290406
PMCPMC13266581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.